Literature DB >> 26131190

Osteoporosis biomarkers act as predictors for diagnosis of chronic renal insufficiency in elder patients.

Zhong-Xin Li1, Chen Xu1, Yan-Chun Li1, Qian-Mei Sun2.   

Abstract

Chronic renal insufficiency and osteoporosis have become very common among old people in China. Hyperparathyroidism caused by renal insufficiency would result in turbulence of bone metabolism and unbalance between serum calcium and phosphorus. The aim of this study is to investigate the BMD, PTH, CT and 25(OH)-Vit's significance for screening and diagnosing chronic renal insufficiency. In this study, seventy cases with chronic renal insufficiency from Jun. 2010 to Oct. 2013 were selected as the observation group. Meanwhile, another 70 volunteers with normal renal functions were set as the control group. The level of BMD, PTH, CT and 25(OH)-Vit were detected by using ELISA assay. DPX bone density meters (UNIGAMMA X-RAY PLUS) were used for the detection of BMD. The results indicated that BMD levels of the proximal femur (include Troch, Shaft, Total, Neck, Ward) and lumbar vertebra in the observation group were significantly lower while the PTH and CT were significantly higher compared with the control group (P<0.05). A positive correlation was identified between the serum creatinine (Scr) concentrations and CT, PTH, while the correlation with 25(OH)-Vit was considered to be negative. In conclusion, the BMD, PTH, CT, and 25 (OH)-Vit would provide reference in diagnosing and treatment for chronic renal insufficiency. These indexes would be important clinical significance for screening and early diagnose of osteoporosis in these patients.

Entities:  

Keywords:  Chronic renal insufficiency; bone mineral density; correlation; influence factors; progress

Year:  2015        PMID: 26131190      PMCID: PMC4483914     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?

Authors:  C Tzanno-Martins; E Futata; V Jorgetti; A J Duarte
Journal:  Clin Nephrol       Date:  2000-07       Impact factor: 0.975

2.  Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.

Authors:  Masakazu Kogawa; David M Findlay; Paul H Anderson; Renee Ormsby; Cristina Vincent; Howard A Morris; Gerald J Atkins
Journal:  Endocrinology       Date:  2010-08-25       Impact factor: 4.736

Review 3.  Update in vitamin D.

Authors:  John S Adams; Martin Hewison
Journal:  J Clin Endocrinol Metab       Date:  2010-02       Impact factor: 5.958

4.  Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.

Authors:  S Boonen; S Mohan; J Dequeker; J Aerssens; D Vanderschueren; G Verbeke; P Broos; R Bouillon; D J Baylink
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

5.  Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis.

Authors:  Yousry Mostafa Hussien; Amal Shehata; Rehab A Karam; Saad S Alzahrani; Hanem Magdy; Abeer M El-Shafey
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

6.  The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.

Authors:  P Messa; G Mioni; D Turrin; U P Guerra
Journal:  Nephrol Dial Transplant       Date:  1995-12       Impact factor: 5.992

7.  Circulating levels of erythropoietin and its relation to arterial stiffness in patients with hypertension.

Authors:  Omer Gedikli; Abdulkadir Kiris; Caner Karahan
Journal:  Int J Clin Exp Med       Date:  2013-09-01

8.  Prevalence of vitamin D deficiency in chronic liver disease.

Authors:  J Arteh; S Narra; S Nair
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

9.  Parathyroid hormone-related protein expression, in combination with nodal status, predicts bone metastasis and prognosis of breast cancer patients.

Authors:  Keiichi Takagaki; Tsutomu Takashima; Naoyoshi Onoda; Kenji Tezuka; Eiji Noda; Hidemi Kawajiri; Tetsuro Ishikawa; Kosei Hirakawa
Journal:  Exp Ther Med       Date:  2012-03-21       Impact factor: 2.447

10.  Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.

Authors:  Harald Kotzmann; Michaela Riedl; Peter Pietschmann; Alice Schmidt; Ernst Schuster; Sören Kreuzer; Franz Kainberger; Herwig Frisch; Georg Geyer; Walter H Hörl; Gert Mayer; Anton Luger
Journal:  J Nephrol       Date:  2004 Jan-Feb       Impact factor: 3.902

View more
  1 in total

1.  Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.

Authors:  Mouna Bouksila; Mehdi Mrad; Wajih Kaabachi; Eya Kalai; Wided Smaoui; Sonia Rekik; Asma Krir; Nesrine Issaoui; Kamel Hamzaoui; Hela Sahli; Elhem Cheour El Kateb; Mohammed Karim Zouaghi; Afef Bahlous
Journal:  J Med Biochem       Date:  2019-07-30       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.